[1] |
Liu Jing, Luo Na, Feng Shangyong, Wang Yan, Zhang Zhenwen, She Dunmin.
Prevalence and risk factors of hyperuricemia in health examination population in Yangzhou, 2020
[J]. Clinical Focus, 2023, 38(5): 428-432.
|
[2] |
Peng Cheng1, Zhang Yuanxin1, Lin Guiying1, Lu Xiaoliang2.
Relationship between serum uric acid level and prognosis of acute ischemic stroke: a metaanalysis
[J]. Clinical Focus, 2020, 35(8): 677-683.
|
[3] |
Zhang Yuanyuana, Duan Junyingb, Zhang Yaxina, Liang Dongmeia, Liu Guoqinga, Li Yana.
A sample research on prevalence and risk factors of amnestic mild cognitive impairment in elderly in Shijiazhuang
[J]. Clinical Focus, 2020, 35(7): 610-615.
|
[4] |
Zhan Yaping, Li Xian, Zhu Xiangshun, Wang Guofen, Tong Xiaojun.
Clinical analysis of adjuvant therapy of bifidobacterium quadruple bacteria in hyperuricemia
[J]. Clinical Focus, 2020, 35(4): 344-347.
|
[5] |
Li Chao1, Song Wenhui2.
Clinical related factors of obese children
[J]. Clinical Focus, 2020, 35(2): 177-180.
|
[6] |
Niu Ying1, Jing Gaojing1, Zhao Nan1, Niu Qianglong1, Yang Fang1, Li Yujuan1, Wu Dan1, Guo Huiping1, Wang Binli1, Song Pei1, Teng Weiping2, Shan Zhongyan2 .
Present situation and influencing factors of diabetes mellitus in Lanzhou residents
[J]. Clinical Focus, 2019, 34(8): 715-719.
|
[7] |
Gao Lixia, Ma Liyan, Peng Chenxing, Guo Huifang.
Major advances in clinical research of rheumatic diseases of 2018
[J]. Clinical Focus, 2019, 34(1): 23-32.
|
[8] |
Wang Mian, Zhang Lihui, Su Shengou.
Clinical advances in endocrine and metabolic disease in 2017
[J]. Clinical Focus, 2018, 33(1): 46-53.
|
[9] |
Yan Wei1, Li Rui2, Zhang Hongbo1, Wang Jieping1, Xu Ying1, Wu Wei1, Yang Xinghua3.
Hypertension on prevalence and influencing factors in a hospital’s checkup population of Beijing
[J]. Clinical Focus, 2017, 32(6): 483-486.
|
[10] |
Peng Guangze, Wang Siting, Yang Chuanpeng, Chen Hongxia, Ke Juan, Wang Lixia.
Hypertension risk factors in Guanping residents
[J]. Clinical Focus, 2017, 32(11): 974-976.
|
[11] |
Ying Ying1,Li Zhen1,Huang Haiyan1, Zou Rongxin1, Li Xiaoke1, Chen Yong2.
Correlation between P2RX7 gene polymorphism and primary gout and hyperuricemia
[J]. Clinical Focus, 2017, 32(1): 59-63.
|
[12] |
Zhang Mingfeng, Guo Huifang, Gao Lixia.
Pay attention to the influence and prevention strategy of hyperuricemia on metabolic syndrome and cardiovascular disease
[J]. Clinical Focus, 2016, 31(5): 496-500.
|
[13] |
Chen Xiaoyun1a,Ma Shungao1b,Yang Chun1a,Gao Yujie1a,Sha Yanmei1a,Yao Xiuzhen2,Li Weijuan1a,Tang Zhengqiao1a,Wang Xiaofen1a,.
Correlation study between serum uric acid and metabolic syndrome and risk factors in Dali Bai population in Yunnan
[J]. Clinical Focus, 2016, 31(12): 1308-1312,1317.
|
[14] |
Wang Yue;Shi Like;Zhang Lutao;Liu Yan;Jia Yuan;Wang Liyi;Wang Shibo.
Survey on prevalence rate of nosocomial infection from a three-class A hospital in three years
[J]. Clinical Focus, 2015, 30(9): 1004-1007.
|
[15] |
Yin Hexin;Jia Zhenxiang;Liang Liqing;Liu Jingqin.
Factors related to hyperuricemia in patients with new-onset type 2 diabetes mellitus
[J]. Clinical Focus, 2015, 30(7): 803-805.
|